Following the acquisition of Lung Therapeutics in October 2023, Aileron is shifting its disease focus to advancing a pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis diseases, including LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusion (LPE). For more information about the company, please visit our website.
View Top Employees from Aileron Therapeutics| Website | http://aileronrx.com |
| Ticker | ALRN |
| Revenue | $355000 |
| Funding | $56.2 million |
| Employees | 18 (18 on RocketReach) |
| Founded | 2005 |
| Address | 285 Summer Street, Boston, Massachusetts 02210, US |
| Phone | (617) 995-0900 |
| Fax | (617) 995-2410 |
| Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Biopharma, Drug Discovery, Drug Development, Pharmaceuticals, Stapled Peptides, Healthcare, Health Care, Biopharmaceuticals, Science and Engineering, Chemistry, Therapeutics |
| Web Rank | 8 Million |
| Keywords | Aileron Therapeutics, Aileron, P53 Cancer Clinical Trial, Stapled Peptides |
| Competitors | Angiochem, Bicycle Therapeutics, Protalex, Inc., Vedanta Biosciences, Inc., Visterra Inc. |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Aileron Therapeutics employee's phone or email?
Aileron Therapeutics Questions
The Aileron Therapeutics annual revenue was $355000 in 2024.
Manuel Aivado is the President and Chief Executive Officer of Aileron Therapeutics.
18 people are employed at Aileron Therapeutics.
Aileron Therapeutics is based in Boston, Massachusetts.
The NAICS codes for Aileron Therapeutics are [541714, 54, 5417, 541, 54171].
The SIC codes for Aileron Therapeutics are [873, 87].
Top Aileron Therapeutics Employees
-
5+5+
-
24
-
12
-
ViewAndres Brainsky
Vice President Clinical Development at Aileron Therapeutics
Collegeville, Pennsylvania, United States21 -
24
-
View
Rachael Perry
Corporate Controller at Aileron Therapeutics
Boston, Massachusetts, United States4
Related Companies
